Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.72
-0.60 (-3.11%)
Oct 2, 2026, 2:49 PM EDT - Market open
Legend Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Reiterates $28 → $24 | Hold | Reiterates | $28 → $24 | +28.21% | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $65 | Buy | Reiterates | $65 | +247.22% | Sep 28, 2026 |
| Barclays | Barclays | Buy Maintains $78 → $74 | Buy | Maintains | $78 → $74 | +295.30% | Sep 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $58 | Buy | Maintains | $58 | +209.83% | Sep 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +156.41% | Aug 12, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $41 → $41 | Buy | Maintains | $41 → $41 | +117.41% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades $75 → $40 | Hold | Downgrades | $75 → $40 | +113.68% | Aug 12, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $29 → $24 | Hold | Reiterates | $29 → $24 | +28.21% | Aug 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.